January 18, 2007

1 Min Read
Glykon Invokes Patent Interference at the USPTO

LAS VEGAS, Jan. 17 /PRNewswire/ -- Glykon Technologies Group, LLC has
invoked Patent Interference Proceedings at the United States Patent and
Trademark Office (USPTO) against Alex Moffett of Renaissance Herbs ("RHI")
and Parag Shah of Dhanvantari Botanicals for an improper patent application
filing that fails to list true inventors of compounds based upon
(-)-hydroxycitric acid and the processes for making such compounds. These
new hydroxycitrate compounds are pertinent to the areas of pharmaceutical
development and use in foods and beverages. Interference Proceedings will
prevent action on the application at the USPTO until a ruling has been made
and will have ramifications in all countries that are signatories to the
Patent Convention Treaty (PCT), which covers intellectual property matters
internationally. Interference Proceedings also mean that the application
cannot be sold or transferred.

Subscribe and receive the latest updates on trends, data, events and more.
Join 57,000+ members of the natural products community.

You May Also Like